We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Using CDRH’s Medical Device Quality Data to Improve Your Bottom Line - Webinar CD/Transcript

Other Options

Audio CD/Transcript - Aug. 9, 2017

$287.00

Audio CD/Transcript - Aug. 9, 2017

$258.00

Audio CD/Transcript - Aug. 9, 2017

$244.00

Audio CD/Transcript - Aug. 9, 2017

$230.00

Audio CD/Transcript - Aug. 9, 2017

$215.00

Using CDRH’s Medical Device Quality Data to Improve Your Bottom Line - Webinar CD/Transcript

$287.00
Webinar Recordings

Product Details

Using CDRH’s Medical Device Quality Data to Improve Your Bottom Line

The “CY2016 Annual FDA Medical Device Quality System Data” report is an information goldmine for devicemakers — a key to better inspection outcomes as well as greater quality in manufacturing.

In its pages you’ll discover hot-off-the-press aggregate data on inspections, Form 483 observations and warning letter citations that you can use to increase quality in manufacturing and compliance.

Sadly, not enough devicemakers know how to get the most out of this valuable annual report from the CDRH.

But Michael Gaba, Cisco Vicenty and Daniel Walter do. And they’re about to show you.

Mr. Gaba — an attorney with Polsinelli LLP — Mr. Vicenty — the Program Manager for the Case for Quality within the Office of Compliance at FDA’s Center for Devices and Radiological Health — and Mr. Walter — Chief, Foreign Enforcement Branch, Division of International Compliance Operations, Office of Compliance, CDRH — will help you get better inspection outcomes, boost manufacturing quality, and avoid FDA sanctions.

Participants will discover:

  • Missteps that trigger warning letters and 483s
  • How to use CDRH compliance data to improve inspection outcomes
  • How to boost manufacturing quality using CDRH compliance data
  • How to sift the raw numbers for gold — key data and statistical trends
  • Compliance strategies to avoid post-inspection escalation
  • And much more!
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing